Zang, H., Qian, G., Arbiser, J., Owonikoko, T. K., Ramalingam, S. S., Fan, S., & Sun, S. (2020). Overcoming acquired resistance of EGFR‐mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiol. Mol Oncol.

Zang, Hongjing, Guoqing Qian, Jack Arbiser, Taofeek K. Owonikoko, Suresh S. Ramalingam, Songqing Fan, and Shi‐Yong Sun. "Overcoming Acquired Resistance of EGFR‐mutant NSCLC Cells to the Third Generation EGFR Inhibitor, Osimertinib, With the Natural Product Honokiol." Mol Oncol 2020.

Zang, Hongjing, et al. "Overcoming Acquired Resistance of EGFR‐mutant NSCLC Cells to the Third Generation EGFR Inhibitor, Osimertinib, With the Natural Product Honokiol." Mol Oncol 2020.